Gene Therapy Trial in Patients with B0/B0 Genotype Begins in Chicago

July 19, 2017- Bluebird bio has now initiated the gene therapy trial in transfusion-dependent beta-thalassemia patients with the B0/B0 genotype. The Lurie Children’s Hospital in Chicago is currently enrolling patients for this study.

Further information about this trial can be found at: https://clinicaltrials.gov/ct2/show/NCT03207009?cond=thalassemia+lentiglobin&rank=4

 

The Cooley’s Anemia Foundation provides information on select clinical trials that may be of interest to the thalassemia population. This information is provided for educational purposes only and does not imply an endorsement of any trial. Patients who are considering participating in a clinical trial and do not know what questions to ask may want to consult with CAF Patient Outreach Director Sandy Gilbert (sgilbert@thalassemia.org) who can help them determine what questions they should ask the investigators to determine if a trial is right for them.


Secured By miniOrange